Characteristics of rubber used in pharmaceuticals

Norwood, Daniel L.; Ruberto, Michael; DeGrazio, Fran L.; Castner, Jim; Wong, Wai Kueng; Jenke, Dennis
June 2009
Rubber & Plastics News;6/29/2009, Vol. 38 Issue 24, p15
Trade Publication
The article presents information on the rubber used in packaging of pharmaceutical products. Rubber materials, in certain situations, possess the required performance characteristics and thus are widely used in the pharmaceutical industry. In the U.S. and European Union regulatory agencies have issued guidance and guidelines to specifically address packaging systems and their materials of construction used for pharmaceutical products.


Related Articles

  • European Union Packaging Safety Features Come into Effect. Milmo, Sean // Pharmaceutical Technology;Mar2014, Vol. 38 Issue 3, p20 

    The article discusses the implementation of the safety and security features of medicines packaging in compliance with the European Union's Falsified Medicines Directive (FMD). It mentions the approval of the FMD in 2011 to fight against the increasing number of falsified drugs in the EU. Domino...

  • Time to spot the pack potential? Creasey, Simon // Packaging News;Oct2014, p32 

    The article focuses on packaging of pharmaceutical products, citing need of innovations in the packaging. Topics discussed include spending of the pharmaceutical industry of Great Britain on research and development, supposed low amount of spending made by eh industry on product packaging,...

  • The 2010 EU Braille mandate.  // Pharmaceutical Technology Europe;Nov2009, Vol. 21 Issue 11, p31 

    The article discusses the implication of the 2010 Braille mandate from the European Union (EU) for the pharmaceutical industry in Europe. The mandate obliged drug manufacturers to include Braille text of the uncontracted forms of a drug name and strength on newly accepted medicines. However,...

  • Translation requirements for generics in the EU. Safar, Libor // MultiLingual;Sep2013, Vol. 24 Issue 6, p44 

    The article offers information on the requirements of translation of generic medicines in European Union countries. It mentions that as generics differ in inactive ingredients (excipients), such as colorings, appearance and packaging, and they should have the same authorization as the patented...

  • in brief.  // Pharmaceutical Technology Europe;May2004, Vol. 16 Issue 5, p10 

    This article presents news briefs, related to the pharmaceutical industry. The European Union Competitiveness Council has adopted the pharmaceutical legislation review package, thereby effectively finalizing the co-decision procedure, following a vote in the European Parliament on December 17,...

  • Curbing counterfeits in the EU. Milmo, Sean // Pharmaceutical Technology Europe;Jul2011, Vol. 23 Issue 7, p14 

    The article discusses the approval of the European Union's Falsified Medicines Directive (FMD) which aims to combat counterfeit medicines in Europe. It states that the legislation is yet to be polished with the efforts of the European Commission (EC) which was assigned by the EU to implement the...

  • Serialization Shake Out. Milmo, Sean // Pharmaceutical Technology;Oct2015, Vol. 39 Issue 10, p20 

    The article discusses the complexities of the new packaging regulations laid out by the European Falsified Medicines Directives (FMD) that is said to pressurize the existence of pharmaceuticals and packaging companies. Topics discussed include views of Bart Vansteenkiste, European Union life...

  • European Union Packaging Safety Features Come into Effect. Milmo, Sean // Pharmaceutical Technology Europe;Mar2014, Vol. 26 Issue 3, p8 

    The article focuses on the impact of the European Union's rules on the security of medicines packaging, part of the Falsified Medicines Directive (FMD), on drug manufacturers trying to comply with the rules. Topics include the printing of unique identifier codes on drug packaging, remarks from...

  • Packaging & Serialization. Barlas, Stephen // Contract Pharma;Mar2011, Vol. 13 Issue 2, p56 

    The article discusses the move of the U.S. Food and Drug Administration (FDA) to develop packaging track and trace systems on pharmaceutical products. It notes that such move serves as frontrunners of the federal requirement to publish item-level track and trace standards for interoperability,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics